The Effect of Selected Nitric Oxide Synthase Polymorphisms on the Risk of Developing Diabetic Nephropathy.

BACKGROUND

Nitric oxide synthase (NOS) is an enzyme that catalyzes the formation of nitric oxide (NO), the altered production of which is characteristic of diabetic nephropathy. NOS exists in three isoforms: NOS1, NOS2, and NOS3. Moreover, there are reports about the potential role of polymorphisms in the development of diabetes complications. The aim of this study was to assess the role of selected polymorphisms-rs3782218 (), rs1137933 (), rs1799983, rs2070744, and rs61722009 ()-in the risk of developing diabetic nephropathy and in the likelihood of renal replacement therapy.

METHODS

The studied polymorphisms were analyzed in a group of 232 patients divided into three groups. Four polymorphisms (rs3782218, rs1137933, rs1799983, rs2070744) were genotyped using the PCR-RFLP, while the rs61722009 polymorphism was genotyped using the PCR.

RESULTS

The C/C genotype and the C allele of the rs3782218 polymorphism () were associated with an increased risk of developing diabetic nephropathy and an increased likelihood of renal replacement therapy. In turn, the G allele of the rs1137933 polymorphism () reduces the likelihood of renal replacement therapy.

CONCLUSIONS

The specific genotypes or alleles of the rs3782218 () and rs1137933 () polymorphisms seem to be potential risk factors for diabetic nephropathy and renal replacement therapy.